Peddle, C., & MacLaren, R. (2021). Development of all-in-one CRISPR/Cas9 and CRISPRi AAV constructs to treat autosomal dominant retinitis pigmentosa.
Cita Chicago (17th ed.)Peddle, CF, i RE MacLaren. Development of All-in-one CRISPR/Cas9 and CRISPRi AAV Constructs to Treat Autosomal Dominant Retinitis Pigmentosa. 2021.
Cita MLA (9th ed.)Peddle, CF, i RE MacLaren. Development of All-in-one CRISPR/Cas9 and CRISPRi AAV Constructs to Treat Autosomal Dominant Retinitis Pigmentosa. 2021.
Atenció: Aquestes cites poden no estar 100% correctes.